EXPERIENCE OF USING PD-1 CHECKPOINT INHIBITOR PROLGOLIMAB IN REAL CLINICAL PRACTICE IN A PATIENT WITH MULTIPLE METASTASES OF MELANOMA FROM AN UNKNOWN PRIMARY SITE
V.E. Askarov1, K.V. Menshikov1,2, Sh.I. Musin1, A.F. Nasretdinov1, N.I. Sultanbaeva1, I.A. Menshikova2, A.V. Sultanbaev1 1Republican Clinical Oncology Dispensary, Ufa 2Bashkir State Medical University, Ufa Askarov Vadim E. ― oncologist, head of the anti-tumor drug therapy department of the Republican Clinical Oncology Dispensary (Sterlitamak branch) 73/1 Oktyabrya Ave., Ufa, 450054, Russian Federation, e-mail: ufa.askarov@gmail.com, ORCID ID: … Читать далее